"FDA grants ODD to Tempest’s hepatocellular carcinoma treatment" was originally created and published by Pharmaceutical ...

But the man’s condition worsened, progressing into cirrhosis and eventually hepatocellular carcinoma, also known as liver ...

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications ...

Liver cells attempt to shut down as a defense mechanism against cancer, but this strategy is not particularly effective.

The liver, serving as the body's natural filtration system, faces significant challenges from alcohol consumption. As this ...

The following is a summary of “Development models to predict complication and prognosis following liver resection for ...

There’s a stigma surrounding liver cancer. Once you tell people you’ve got it, often you sense a slight judgment. “Oh”, you ...

Surgeons at the Mahatma Gandhi Memorial Government Hospital (MGMGH) in Tiruchi have removed a tumour weighing 1.5 kg from the right lobe of a patient’s liver and saved his life on Monday ...

Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Hepatocellular Carcinoma.

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• NAYA aiming to ...

Alcohol-associated hepatitis (AH) is a critical global health issue characterized by acute liver inflammation and an elevated ...